REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jf Draf Pharmaceuticals Corp. (Philippines)

Main Activities: Shoe Stores
Full name: Jf Draf Pharmaceuticals Corp. Profile Updated: December 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The subject is engaged in trading, importing and exporting, distributing and marketing pharmaceuticals products, medical supplies, devices, equipment and other related products.

Headquarters
Rm. 407 Greenhills Mansion, 37 Annapolis St., Greenhills Metro Manila
San Juan;

Contact Details: Purchase the Jf Draf Pharmaceuticals Corp. report to view the information.

Basic Information
Financial Auditors:
Purchase the Jf Draf Pharmaceuticals Corp. report to view the information.
Incorporation Date:
January 18, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
20%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Jf Draf Pharmaceuticals Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-1.71%▼
Total operating revenue
-1.71%▼
Operating profit (EBIT)
-86.36%▼
EBITDA
-63.7%▼
Net Profit (Loss) for the Period
-88.25%▼
Total Assets
3.8%▲
Total Equity
0.95%▲
Operating Profit Margin (ROS)
-1.46%▼
Net Profit Margin
-2.25%▼
Return on Equity (ROE)
12.21%▲
Debt/Equity
-0.13%▼
Quick Ratio
0.18%▲
Cash Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo